CA3053507A1 - Compositions for treating acne - Google Patents

Compositions for treating acne Download PDF

Info

Publication number
CA3053507A1
CA3053507A1 CA3053507A CA3053507A CA3053507A1 CA 3053507 A1 CA3053507 A1 CA 3053507A1 CA 3053507 A CA3053507 A CA 3053507A CA 3053507 A CA3053507 A CA 3053507A CA 3053507 A1 CA3053507 A1 CA 3053507A1
Authority
CA
Canada
Prior art keywords
solvent
ethoxyethoxy
ethanol
pharmaceutical composition
alcohol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3053507A
Other languages
English (en)
French (fr)
Inventor
Eugene Cooper
Matthew CALLAHAN
Michael Thurn
David Dickason
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Botanix Pharmaceuticals Ltd
Botanix Pharmaceuticals Inc
Original Assignee
Botanix Pharmaceuticals Ltd
Botanix Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2017900498A external-priority patent/AU2017900498A0/en
Application filed by Botanix Pharmaceuticals Ltd, Botanix Pharmaceuticals Inc filed Critical Botanix Pharmaceuticals Ltd
Priority claimed from PCT/AU2018/050117 external-priority patent/WO2018148795A1/en
Publication of CA3053507A1 publication Critical patent/CA3053507A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA3053507A 2017-02-15 2018-02-14 Compositions for treating acne Pending CA3053507A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762459312P 2017-02-15 2017-02-15
AU2017900498A AU2017900498A0 (en) 2017-02-15 Compositions for Treating Acne
US62/459,312 2017-02-15
AU2017900498 2017-02-15
PCT/AU2018/050117 WO2018148795A1 (en) 2017-02-15 2018-02-14 Compositions for treating acne

Publications (1)

Publication Number Publication Date
CA3053507A1 true CA3053507A1 (en) 2018-08-23

Family

ID=67766788

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3053507A Pending CA3053507A1 (en) 2017-02-15 2018-02-14 Compositions for treating acne

Country Status (8)

Country Link
US (2) US20200022927A1 (enExample)
EP (1) EP3582763A4 (enExample)
JP (1) JP2020508993A (enExample)
CN (1) CN110430872A (enExample)
AU (1) AU2018221889A1 (enExample)
BR (1) BR112019017045A2 (enExample)
CA (1) CA3053507A1 (enExample)
IL (1) IL268715A (enExample)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2338124C (en) * 2001-02-26 2010-08-03 Valerie Dumont Dicianna Self-tanning composition in sheeted substrate
FR2867682B1 (fr) * 2004-03-22 2009-06-05 Galderma Res & Dev Composition pharmaceutique anhydre associant un agent silicone et un principe actif solubilise.
WO2009090495A2 (en) * 2007-12-07 2009-07-23 Foamix Ltd. Oil and liquid silicone foamable carriers and formulations
US20100261795A1 (en) * 2009-04-08 2010-10-14 Pierre Fabre Dermocosmetique Usa Antiacneic compositions
JP5964322B2 (ja) * 2011-01-13 2016-08-03 キュー エル ティー インク．ＱＬＴ Ｉｎｃ． 光増感剤の局所送達用医薬組成物及びその使用
US20150141389A1 (en) * 2012-04-27 2015-05-21 Dow Corning Corporation Topical Formulation Compositions Containing Silicone Based Excipients To Deliver Actives To A Substrate
CA2888060C (en) * 2012-10-24 2019-02-26 John E. Kulesza Low toxicity topical active agent delivery system
WO2014081674A1 (en) * 2012-11-20 2014-05-30 Allergan, Inc. Topical dapsone and dapsone/adapalene compositions and methods for use thereof
WO2014116653A1 (en) * 2013-01-22 2014-07-31 Coty Inc. Topical formulations and methods for the use thereof
EP3065702B1 (en) * 2013-10-31 2023-06-07 Sun Pharmaceutical Industries Ltd Topical pharmaceutical composition of acitretin

Also Published As

Publication number Publication date
US20220331269A1 (en) 2022-10-20
JP2020508993A (ja) 2020-03-26
EP3582763A1 (en) 2019-12-25
BR112019017045A2 (pt) 2020-04-14
AU2018221889A1 (en) 2019-09-05
CN110430872A (zh) 2019-11-08
IL268715A (en) 2019-10-31
EP3582763A4 (en) 2020-11-25
US20200022927A1 (en) 2020-01-23

Similar Documents

Publication Publication Date Title
RU2429815C2 (ru) Безводная многофазная гелевая система
EP2691077B1 (en) Salicylic acid topical formulation
CA3053503C (en) Formulations of cannabinoids for the treatment of acne
US20210401768A1 (en) Formulations of cannabinoids for the treatment of dermatitis and inflammatory skin diseases
WO2018206962A1 (en) Skin barrier composition
CN102048724A (zh) 用于治疗皮肤的过氧化苯甲酰组合物
WO2018148787A1 (en) Formulations of cannabinoids for the treatment of psoriasis
WO2018148786A1 (en) Formulations of cannabinoids for the treatment of acne
US20110236503A1 (en) Topical Skincare Composition
JP5667052B2 (ja) ダナゾールを含む経真皮医薬組成物
CN1972708A (zh) 用于局部治疗的组合物
Moglia et al. Effects of topical treatment with fenretinide (4-HPR) and plasma vitamin A levels in patients with actinic keratoses
JP2021512067A (ja) ざ瘡のためのカンナビノイド投薬レジメン
US20220331269A1 (en) Compositions for treating acne
BRPI0617045B1 (pt) composição, processo para preparar uma composição, uso de uma composição e uso cosmético de uma composição
WO2018148795A1 (en) Compositions for treating acne
US9642877B1 (en) Method of administration of chromium and magnesium sulfate for treatment of acne
US8900601B2 (en) Permeable mixtures, methods and compositions for the skin
JP2006515873A (ja) 哺乳類の皮膚科病変の治療及び／又は予防におけるビタミンｋ１酸化物又はその誘導体を含有する組成物の使用
AU2016427261A1 (en) Pharmaceutical compositions
JP3333428B2 (ja) 皮膚外用剤
US20250170085A1 (en) Topical formulation to decrease skin inflammation or redness
JPS6028927A (ja) 皮膚外用剤
US20220313621A1 (en) Formulations of cannabinoids for the treatment of psoriasis
CA2963110A1 (en) Method of administration of chromium and magnesium sulfate for treatment of acne

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20220210

EEER Examination request

Effective date: 20220210

EEER Examination request

Effective date: 20220210

EEER Examination request

Effective date: 20220210